{"id":239684,"date":"2025-12-18T18:43:24","date_gmt":"2025-12-18T18:43:24","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/239684\/"},"modified":"2025-12-18T18:43:24","modified_gmt":"2025-12-18T18:43:24","slug":"full-list-of-common-drugs-that-will-be-cheaper-under-medicare-next-year","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/239684\/","title":{"rendered":"Full List of Common Drugs That Will Be Cheaper Under Medicare Next Year"},"content":{"rendered":"

Several common drugs will be cheaper next year under Medicare<\/a>, from weight-loss drug Ozempic<\/a> to breast-cancer medication<\/a> Ibrance, according to the Centers for Medicare & Medicaid Services (CMS).<\/p>\n

The Trump administration approved the lower prices for 15 widely used Medicare-covered drugs for next year. Total spending on the drugs should drop by 44 percent, or about $12 billion, CMS officials said.<\/p>\n

Why It Matters<\/p>\n

The price reductions could dramatically help some older adults, but it\u2019s unclear to what extent because Medicare recipients already have an out-of-pocket cap. However, for those who primarily rely on certain medications, the savings could be substantial.<\/p>\n

\"\"What To Know<\/p>\n

The Centers for Medicare & Medicaid Services (CMS) reported that for the 55 million Americans enrolled in Medicare Part D, savings are likely to be $685 million. But because 5.3 million people are estimated to use the 15 medications, the CMS has estimated an average saving of $129 per enrollee.<\/p>\n

The Inflation Reduction Act (IRA) gave Medicare the ability to negotiate the price of certain high-cost drugs for the first time in 2022. Under the new agreement, lower prices will also take place for Medicare Part D prescriptions.<\/p>\n

Discounts will range from 38 percent to 85 percent. Additionally, the IRA set a $2,000 out-of-pocket cap for seniors in 2025. By 2027, the cap is likely to grow to about $2,200, according to the CMS.<\/p>\n

The full list of drugs:<\/p>\n